A Novel First-line Calcium Channel Blocker for Hypertension Management


COMPOSITION: Cilnidipine IP 10 mg

  • Minimizes vascular damage, angioedema and improves patient adherence leading to long term BP control.
  • Cardioprotective, mode of action reduces the risk of cardiovascular diseases.
  • Reduces the need for dose escalation, improves arterial stiffness and offers renoprotection.


  • Hypertension
  • Cardiovascular Disorders
  • Arterial Stiffness
  • Angioedema



            Class of medications: Calcium channel blockers

  • It is a new antihypertensive drug distinguished from other L-type Ca2+ channel blockers.
  • More effective than amlodipine at improving renal function and arterial stiffness in patients with essential.
  • Has an anti-proteinuric effect especially in patients with essential hypertension.
  • Treats mild to moderate essential hypertension.